Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Chronic myelogenous leukemia risk factors
Introduction
Overview
Overview
Common risk factors in the development of chronic myelogenous leukemia include ionizing radiation, formaldehyde, benzene, older age and male gender.
Common Risk Factors
Common Risk Factors
Common risk factors in the development of chronic myelogenous leukemia include: [1][2][3]
- Ionizing radiation
- Older age
- Male gender
Less common Risk Factors
Less common Risk Factors
Less common risk factors in the development of chronic myelogenous leukemia include:[4][5]
- Radiotherapy
- Chemotherapy
- Benzene
- Formaldehyde
- Obesity
- Smoking
- Pesticides
References
References
- ↑ Moloney WC (1987). “Radiogenic leukemia revisited”. Blood. 70 (4): 905–8. PMID 3477299.
- ↑ Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/staging/?region=ab
- ↑ Höglund M, Sandin F, Simonsson B (April 2015). “Epidemiology of chronic myeloid leukaemia: an update”. Ann. Hematol. 94 Suppl 2: S241–7. doi:10.1007/s00277-015-2314-2. PMID 25814090.
- ↑ Strom SS, Yamamura Y, Kantarijian HM, Cortes-Franco JE (May 2009). “Obesity, weight gain, and risk of chronic myeloid leukemia”. Cancer Epidemiol. Biomarkers Prev. 18 (5): 1501–6. doi:10.1158/1055-9965.EPI-09-0028. PMC 2918285. PMID 19423527.
- ↑ Kabat, G. C.; Wu, J. W.; Moore, S. C.; Morton, L. M.; Park, Y.; Hollenbeck, A. R.; Rohan, T. E. (2013). “Lifestyle and Dietary Factors in Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health Study”. Cancer Epidemiology Biomarkers & Prevention. 22 (5): 848–854. doi:10.1158/1055-9965.EPI-13-0093. ISSN 1055-9965.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: James Nasr[2]